Head and Neck Oncology
Clinical research at Vychodoslovensky Onkologicky Ustav a.s. includes human papillomavirus-associated oropharyngeal squamous cell carcinoma, with attention to local disease control and treatment-related toxicity.
- HPV-driven oropharyngeal cancer
- De-escalation of chemoradiotherapy
- Late toxicity assessment
Its activity in this area reflects a focus on refining radiation oncology care for patients with head and neck malignancies.
Genitourinary Oncology
The sponsor is also involved in studies of localized and locally advanced high-risk prostate cancer, with interest in disease control and treatment safety.
- High-risk prostate cancer
- Androgen deprivation therapy
- Biochemical progression
Research in this field centers on combining hormonal therapy with local treatment approaches for prostate malignancy.
Stereotactic Radiotherapy
Another area of interest is the use of stereotactic radiotherapy in cancer care, particularly for prostate cancer in combination with systemic treatment.
- Precision radiotherapy
- Local tumor control
- Gastrointestinal toxicity
This work aligns with clinical interest in advanced radiation-based treatment strategies for solid tumors.
Supportive Oncology and Toxicity Evaluation
The sponsor’s trials also emphasize treatment tolerability, including assessment of genitourinary toxicity, gastrointestinal toxicity, and patient-reported outcomes.
- Adverse event monitoring
- Patient-reported toxicity
- Long-term safety
These interests support evaluation of how cancer therapies affect quality of life and late treatment effects.
